yes it will be great having a $42b daddy.
if the trials go well and everything goes accordingy to plan, they may attempt to mop up the remaining 80% - if not at least they are committed to stem cells and the relationship with mesoblast is in tact.
lets see if any other big pharma is interested in cephalon - or why not go straight for mesoblast if that is the big potential.
MSB is near its peak in a p8ss weak market - pretty good and again this is on no news!
teva bets on msb stem cells , page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |